Paul W. Hoelscher - 21 Jan 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP, CFO
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 21 Jan 2022
Net transactions value: -$212,852
Form type: 4
Filing time: 24 Jan 2022, 16:06:27 UTC
Previous filing: 24 Jan 2022
Next filing: 25 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$0	+5,558	+8.6%	$0.000000	70,138	21 Jan 2022	Direct
transaction	HZNP	Ordinary Shares	Tax liability	$212,852	-2,463	-3.5%	$86.42	67,675	21 Jan 2022	Direct
holding	HZNP	Ordinary Shares						178,389	21 Jan 2022	By Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units (RSUs)	Options Exercise	$0	-5,558	-100%	$0.000000^*	0	21 Jan 2022	Ordinary Shares	5,558		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Form 4 filed on behalf of the Reporting Person on January 6, 2022 inadvertently reported this amount as 178,839.
F2	Each RSU represents a contingent right to receive one ordinary share of the Issuer.